The online version of this article (https://doi.org/10.1186/s13229-018-0187-7) contains supplementary material, which is available to authorized users.
Impairments in social communication are a core feature of Autism Spectrum Disorder (ASD). Because the ability to infer other people’s emotions from their facial expressions is critical for many aspects of social communication, deficits in expression recognition are a plausible candidate marker for ASD. However, previous studies on facial expression recognition produced mixed results, which may be due to differences in the sensitivity of the many tests used and/or the heterogeneity among individuals with ASD. To ascertain whether expression recognition may serve as a diagnostic marker (which distinguishes people with ASD from a comparison group) or a stratification marker (which helps to divide ASD into more homogeneous subgroups), a crucial first step is to move beyond identification of mean group differences and to better understand the frequency and severity of impairments.
This study tested 46 individuals with ASD and 52 age- and IQ-matched typically developing (TD) participants on the Films Expression Task, which combines three key features of real-life expression recognition: naturalistic facial expressions, a broad range of simple and complex emotions, and short presentation time. Test-retest reliability was assessed in 28 individuals who did not participate in the main study and revealed acceptable reliability (ICC r = .74).
Case-control comparisons showed highly significant mean group differences for accuracy (p = 1.1 × 10− 10), with an effect size (Cohen’s d = 1.6), more than twice as large as the mean effect size reported in a previous meta-analysis (Uljarevic and Hamilton, 2012, J Autism Dev Disord). The ASD group also had significantly increased mean reaction times overall (p = .00015, d = .83) and on correct trials (p = .0002, d = .78). However, whereas 63% of people with ASD showed severe deficits (they performed below two standard deviations of the TD mean, a small subgroup (15.3%) performed normally (within one standard deviation of the mean).
These findings indicate that the majority of people with ASD have severe expression recognition deficits and that the Films Expression Test is a sensitive task for biomarker research in ASD. Future work is needed to establish whether ASD subgroups with and without expression recognition deficits differ from one another in terms of their symptom profile or neurobiological underpinnings.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Fifth ed. Arlington: American Psychiatric Publishing; 2013. CrossRef
Charman T. Variability in neurodevelopmental disorders: evidence from autism. In: Riby D, Van Herwegen J, editors. Applied research and key issues in neurodevelopmental disorders. Hove: Routledge Psychology Press; 2015. p. 177–40.
Biomarkers Definition Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69:89–95. CrossRef
Uljarevic M, Hamilton A. Recognition of emotions in autism: a formal meta-analysis. J Autism Dev Disord. 2012;43(7):1517-26.
Wingenbach TSH, Ashwin C. Brosnan: diminished sensitivity and specificity at recognising facial emotion expressions of varying intensity underlie emotion-specific recognition deficits in autism spectrum disorders. Res Autism Spectr Disord. 2017;34:52–61. CrossRef
Wechsler D. Wechsler Abbreviated Scale of Intelligence - Second Edition (WASI-II). London: Pearson; 2011.
Wechsler D. Wechsler Adult Intelligence Scale. Third ed. London: Pearson; 1997.
Baron-Cohen S, Wheelwright S, Skinner R, Martin J, Clubley E. The autism-spectrum quotient (AQ): evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. J Autism Dev Disord. 2001;31:5–17.
George D, Mallery P. SPSS for Windows step by step: a simple guide and reference. Boston: Allyn & Bacon; 2003.
Kaplan R, Saccuzzo D. Psychological testing: principles, applications and issues (5th ed). Belmont: Wadsworth; 2001.
Lombardo MV, Lai M-C, Auyeung B, Holt RJ, Allison C, Smith P, Chakrabarti B, Ruigrok ANV, Suckling J, Bullmore E, et al. Unsupervised data-driven stratification of mentalizing heterogeneity in autism. Sci Rep Oct. 2016;18:18.
Verhallen RJ, Bosten JM, Goodbourn PT, Lawrance-Owen AJ, Bargary G, Mollon JD. General and specific factors in the processing of faces. Vis Res. 2017;141:217-27.
Nemiah JC, Freyberger H, Sifneos PE. Alexithymia: a view of the psychosomatic process. In: Hill OW, editor. Modern trends in psychosomatic medicine. London: Butterworths; 1976.
Loth E, Charman T, Mason L, Tillmann J, Jones EJH, Wooldridge C, Ahmad J, Auyeung B, Brogna C, Ambrosino S, et al. The EU-AIMS Longitudinal European Autism Project (LEAP): design and methodologies to identify and validate stratification biomarkers for autism spectrum disorders. Mol Autism. 2017;8:24. https://doi.org/10.1186/s13229-017-0146-8.
Charman T, Loth E, Tillmann J, Crawley D, Wooldridge C, Goyard D, Ahmad J, Auyeung B, Ambrosino S, Banaschewski T, et al. The EU-AIMS Longitudinal European Autism Project (LEAP): clinical characterisation. Mol Autism. 2017;8:27. https://doi.org/10.1186/s13229-017-0145-9.
- Facial expression recognition as a candidate marker for autism spectrum disorder: how frequent and severe are deficits?
- BioMed Central
Neu in den Fachgebieten Neurologie und Psychiatrie
Meistgelesene Bücher in der Neurologie & Psychiatrie